VALN
Valneva SE
$5.31
+0.05 (+0.95%)
At close · Jul 8
Market Cap
$542.26M
Shares
102,119,642
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.31
Open$5.27
Day$5.26–5.40
52W$5.04–12.25
Avg vol 30d25K
Short int169K · 0.2% float · 6.8d
Short vol33%
Last earningsSep 30, 2025
DataMay 2021–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−36%
below
Price vs 50-day avg
−4%
below
RSI (14)
46
neutral
MACD trend
Positive
52-week position
4%
near low
Momentum
relative strength
1-month return
0%
trailing
6-month return
−47%
trailing
YTD return
−40%
this year
Relative strength
−55%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $8 — 200d above 50d
Institutional flow
Accumulating
1 of 21 funds reported for Jun 30 · net +2.7K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.17% of float · ▼ -6.7% MoM · 6.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
21 holders — near 3-yr high, broad support
Squeeze score
39
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
74%
annualized · 1-yr
Max drawdown
−58%
past year
ATR
4.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−36%
Bearish
Price vs 50-day avg
−4%
Neutral
RSI (14)
46
Neutral
MACD trend
Positive
Bullish
52-week position
4%
Bearish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $6 › 200d $8 — 200d above 50d
Institutional flow
Accumulating
1 of 21 funds reported for Jun 30 · net +2.7K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.17% of float · ▼ -6.7% MoM · 6.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
21 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $5
Now $5 · 4%
52-wk high $12
vs 200-day avg -36%
vs 50-day avg -4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VALN
this stock
Valneva SE
|
$542.26M | -39.8% | — | — | 0.2% |
|
ONC
BeOne Medicines Ltd.
|
$436.30B | -0.6% | +22179.2% | 887.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.2 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VALN | +1.5% | -0.5% | -47.1% | +1.5% | -39.8% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +1.7% | -1.3% | -54.5% | +1.7% | -49.1% |